Results 211 to 220 of about 22,824 (329)
Rats in Epilepsy Research: A Bibliometric Analysis of Citations Between 1969 and 2020 on Experimental Models in Epilepsy. [PDF]
Rubio C +6 more
europepmc +1 more source
Abstract Objective Central to the development of novel antiseizure medications (ASMs) is testing of antiseizure activity in preclinical models. Although various well‐established models exist, their predictive validity across the spectrum of clinical epilepsies has been less clear.
Lyndsey L. Anderson +9 more
wiley +1 more source
Investigation of Anticonvulsant Potential of <i>Morus alba</i>, <i>Angelica archangelica</i>, <i>Valeriana officinalis</i>, and <i>Passiflora incarnata</i> Extracts: In Vivo and In Silico Studies. [PDF]
Suciu F +13 more
europepmc +1 more source
Deciphering SCN2A: A comprehensive review of rodent models of Scn2a dysfunction
Abstract SCN2A encodes for the alpha subunit of the voltage‐gated sodium channel NaV1.2, which is involved in action potential initiation and backpropagation in excitatory neurons. Currently, it is one of the highest monogenetic risk factors for both epilepsy and autism spectrum disorder.
Katelin E. J. Scott +2 more
wiley +1 more source
Abstract Objective Neuropeptides have garnered great interest as potential treatments for epilepsy due to their impact on neuronal excitability through modulation of ion channels and neurotransmitter receptor activity. Neuropeptide Y (NPY) is a 36‐amino acid neuropeptide that is expressed primarily by γ‐aminobutyric acidergic (GABAergic) interneurons ...
Samantha L. Reed +8 more
wiley +1 more source
Special Issue: Molecular Research in Epilepsy and Epileptogenesis. [PDF]
Czuczwar SJ.
europepmc +1 more source
Involuntary Commitment and Forced Psychiatric Drugging in the Trial Courts: Rights Violations as a Matter of Course [PDF]
Gottstein, James B. (Jim)
core +1 more source

